Web Analytics

3 Latest Announced Rounds

  • $225,000,000
    Unknown
    Financial Services
    Oct 28th, 2025
  • $5,000,000
    Seed

    3 Investors

    Office Administration
    Oct 28th, 2025
  • $7,800,000
    Seed

    4 Investors

    Hospital & Health Care
    Oct 28th, 2025
$638.86M Raised in 29 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Sensorium Therapeutics

start up
United States - Boston, Massachusetts
  • 03/09/2025
  • Series A
  • $25,000,000

Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more.


Related People

Jacob HookerFounder

Jacob Hooker United States - Cambridge, Massachusetts

My mission is to transform the way we treat brain and mental health conditions—bringing bold science to bear on one of the most urgent challenges of our time. Deeply trained as a scientist and shaped by academia, I’ve built a career turning ideas into action, leading efforts that push the boundaries of what’s possible in neuroscience and therapeutic innovation. As a biotech entrepreneur and executive, I work at the intersection of science and strategy to build ventures with real-world impact. I’m driven by a vision of mental health care that’s more effective, more human, and deeply grounded in science.